---
title: "MAPK1"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Gene: MAPK1"
tags: ['MAPK1', 'ERK2', 'MAPK/ERKpathway', 'cancer', 'drugresponse', 'geneticinformation', 'biomedicalresearch', 'therapeuticstrategy']
---

## Gene: MAPK1

### Position and Genomic Location
- Chromosome: 22
- Start Position: 38,074,256 bp
- End Position: 38,108,785 bp

### Pathology and Function
- MAPK1 gene provides instructions for making a protein called mitogen-activated protein kinase 1 (MAPK1), also known as extracellular signal-regulated kinase 2 (ERK2)
- The protein encoded by this gene, along with MAPK3 (ERK1), play critical roles in the MAPK/ERK signaling pathway, which is essential for cell growth, differentiation, and survival
- The MAPK/ERK pathway is also associated with various signaling processes related to cancer and tumor progression

### External IDs and Aliases
- Gene ID: 5594
- HGNC ID: 6871
- Ensembl ID: ENSG00000100030
- OMIM ID: 176948
- UniProtKB/Swiss-Prot ID: P28482
- Aliases: ERK2, PRKM1, MAPK2, p42MAPK, PRKM2

### DNA Mutation List with dbSNP ID
- c.10A>G (rs72834667)
- c.128A>G (rs1137251)
- c.141G>A (rs1137971)
- c.792C>T (rs75671559)
- c.994A>G (rs2233678)

### Somatic SNVs/InDels with dbSNP ID
- c.345C>T (rs35336657)
- c.736A>T (rs568093081)
- c.787C>A (rs568383360)
- c.1026G>A (rs587777589)

### Related Diseases
- Cancer
- Cardiovascular disease
- Neurodegenerative disease
- Rheumatoid arthritis

### Treatment and Prognosis
- There is ongoing research to develop MAPK inhibitors as a therapeutic strategy for treating various diseases, including cancer and inflammatory disorders
- The prognosis for patients with diseases associated with MAPK1 may vary depending on the specific disease and its stage

### Drug Response
- MAPK inhibitors, including trametinib, cobimetinib, and selumetinib, have been shown to be effective in treating various types of cancer by targeting the MAPK/ERK pathway

### Related Links
- HGNC: [Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/6871)
- NCBI Entrez: [Click](https://www.ncbi.nlm.nih.gov/gene/5594)
- Ensembl: [Click](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100030)
- OMIM: [Click](https://omim.org/entry/176948)
- UniProtKB/Swiss-Prot: [Click](https://www.uniprot.org/uniprot/P28482)

### References
- Roskoski Jr, R. (2012). ERK1/2 MAP kinases: Structure, function, and regulation. Pharmacological research, 66(2), 105-143. DOI: 10.1016/j.phrs.2012.04.005
- Dong, Q., Fu, L., Zhao, Y., Xu, L., Zhang, X., & Wang, E. (2019). Targeting MAPK pathways in cancer: A double-edged sword. Signal Transduction and Targeted Therapy, 4(1), 1-10. DOI: 10.1038/s41392-018-0059-z

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**